Literature DB >> 6428496

Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in mice.

R Boden, R Botting, P Coulson, G Spanswick.   

Abstract

The LD50 of pethidine was determined in mice pretreated (4 h) either with the nonselective monoamine oxidase (MAO) inhibitor, phenelzine or with clorgyline, a selective inhibitor of MAO A or deprenyl, a selective inhibitor of MAO B. Phenelzine or combined clorgyline plus deprenyl pretreatments decreased pethidine LD50. Clorgyline or deprenyl alone did not affect pethidine toxicity. Whole brain 5-hydroxytryptamine (5-HT) concentrations were measured in the pretreated mice. 5-HT levels were approximately doubled (P less than 0.001) after phenelzine or clorgyline plus deprenyl treatment, but not after clorgyline or deprenyl given alone. These results indicate that both MAO A and MAO B need to be inhibited to increase pethidine toxicity and brain 5-HT levels. They support the involvement of 5-HT in the toxic interaction between pethidine and MAO inhibitors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428496      PMCID: PMC1987263          DOI: 10.1111/j.1476-5381.1984.tb16452.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer.

Authors:  J Knoll; Z Ecseri; K Kelemen; J Nievel; B Knoll
Journal:  Arch Int Pharmacodyn Ther       Date:  1965-05

2.  The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.

Authors:  H Y Yang; N H Neff
Journal:  J Pharmacol Exp Ther       Date:  1974-06       Impact factor: 4.030

3.  Influence of phenelzine on the toxicity of some analgesics in mice.

Authors:  A J Jounela
Journal:  Ann Med Exp Biol Fenn       Date:  1970

4.  Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain.

Authors:  G Curzon; A R Green
Journal:  Br J Pharmacol       Date:  1970-07       Impact factor: 8.739

5.  The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.

Authors:  K J Rogers; J A Thornton
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

6.  Further studies on the inhibition of monoamine oxidase by M and B 9302 (clorgyline). I. Substrate specificity in various mammalian species.

Authors:  D W Hall; B W Logan; G H Parsons
Journal:  Biochem Pharmacol       Date:  1969-06       Impact factor: 5.858

7.  Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.

Authors:  A R Green; M B Youdim
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

8.  The inhibition of A and B forms of MAO in the production of a characteristic behabioural syndrome in rats after 1-tryptophan loading.

Authors:  R F Squires; J B Lassen
Journal:  Psychopharmacologia       Date:  1975

9.  The role of 5-hydroxytryptamine and noradrenaline in the hyperthermic reaction induced by pethidine in rabbits pretreated with pargyline.

Authors:  I Fahim; M Ismail; O H Osman
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

10.  Comparison of the effects of morphine, pethidine and pentazocine in rabbits pretreated with a monoamine oxidase inhibitor.

Authors:  R G Penn; K J Rogers
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

View more
  4 in total

Review 1.  MAOIs to RIMAs in anaesthesia--a literature review.

Authors:  S Hill; K Yau; J Whitwam
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Advances in opioid pharmacology.

Authors:  Geoffrey K Gourlay
Journal:  Support Care Cancer       Date:  2004-12-21       Impact factor: 3.603

3.  An analgesic effect of enkephalinase inhibition is modulated by monoamine oxidase-B and REM sleep deprivations.

Authors:  O E Ukponmwan; J Rupreht; M Dzoljic
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

Review 4.  Safety of selegiline (deprenyl) in the treatment of Parkinson's disease.

Authors:  E H Heinonen; V Myllylä
Journal:  Drug Saf       Date:  1998-07       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.